학술논문
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan
Document Type
Article
Author
Source
In: Clinical Drug Investigation . (Clinical Drug Investigation, April 2024, 44(4):261-269)
Subject
Language
English
ISSN
11791918
11732563
11732563